These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 7585589

  • 1. Adenovirus-mediated gene therapy of hepatocellular carcinoma using cancer-specific gene expression.
    Kaneko S, Hallenbeck P, Kotani T, Nakabayashi H, McGarrity G, Tamaoki T, Anderson WF, Chiang YL.
    Cancer Res; 1995 Nov 15; 55(22):5283-7. PubMed ID: 7585589
    [Abstract] [Full Text] [Related]

  • 2. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.
    Hepatology; 1996 Jun 15; 23(6):1359-68. PubMed ID: 8675152
    [Abstract] [Full Text] [Related]

  • 3. Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinoma.
    Sakai Y, Kaneko S, Nakamoto Y, Kagaya T, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2001 Oct 15; 8(10):695-704. PubMed ID: 11687892
    [Abstract] [Full Text] [Related]

  • 4. Gene therapy targeting for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by a hypoxia-inducible enhancer linked to a human alpha-fetoprotein promoter.
    Ido A, Uto H, Moriuchi A, Nagata K, Onaga Y, Onaga M, Hori T, Hirono S, Hayashi K, Tamaoki T, Tsubouchi H.
    Cancer Res; 2001 Apr 01; 61(7):3016-21. PubMed ID: 11306481
    [Abstract] [Full Text] [Related]

  • 5. Gene therapy for hepatoma cells using a retrovirus vector carrying herpes simplex virus thymidine kinase gene under the control of human alpha-fetoprotein gene promoter.
    Ido A, Nakata K, Kato Y, Nakao K, Murata K, Fujita M, Ishii N, Tamaoki T, Shiku H, Nagataki S.
    Cancer Res; 1995 Jul 15; 55(14):3105-9. PubMed ID: 7541712
    [Abstract] [Full Text] [Related]

  • 6. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T, Caplen NJ, Ramsey WJ, Onodera M, Shimazaki K, Nomoto T, Ajalli R, Wildner O, Morris J, Kume A, Hamada H, Blaese RM, Ozawa K.
    J Gene Med; 2004 Mar 15; 6(3):288-99. PubMed ID: 15026990
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene.
    Yang L, Hwang R, Chiang Y, Gordon EM, Anderson WF, Parekh D.
    Clin Cancer Res; 1998 Mar 15; 4(3):731-41. PubMed ID: 9533543
    [Abstract] [Full Text] [Related]

  • 8. Retrovirus-mediated herpes simplex virus thymidine kinase gene therapy approach for hepatocellular carcinoma.
    Gao Ding Cheng, An W, Dai J.
    Cell Res; 1999 Sep 15; 9(3):225-35. PubMed ID: 10520605
    [Abstract] [Full Text] [Related]

  • 9. Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.
    Tjuvajev JG, Chen SH, Joshi A, Joshi R, Guo ZS, Balatoni J, Ballon D, Koutcher J, Finn R, Woo SL, Blasberg RG.
    Cancer Res; 1999 Oct 15; 59(20):5186-93. PubMed ID: 10537296
    [Abstract] [Full Text] [Related]

  • 10. Retrovirus-mediated gene therapy for hepatocellular carcinoma: selective and enhanced suicide gene expression regulated by human alpha-fetoprotein enhancer directly linked to its promoter.
    Mawatari F, Tsuruta S, Ido A, Ueki T, Nakao K, Kato Y, Tamaoki T, Ishii N, Nakata K.
    Cancer Gene Ther; 1998 Oct 15; 5(5):301-6. PubMed ID: 9824049
    [Abstract] [Full Text] [Related]

  • 11. [The adenovirus-mediated HSV-TK/GCV suicide gene system in the treatment of tongue carcinoma cell line].
    Huang H, Wang A.
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Nov 15; 36(6):457-60. PubMed ID: 11930726
    [Abstract] [Full Text] [Related]

  • 12. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H, Lu R, Ding R, Kan YW.
    Mol Ther; 2000 Jun 15; 1(6):509-15. PubMed ID: 10933975
    [Abstract] [Full Text] [Related]

  • 13. [Effects of retrovirus-mediated HSV-tk/GCV on human hepatocellular carcinoma].
    Zhao Y, Zhang X, Hui H.
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun 15; 7(2):113-5. PubMed ID: 10488424
    [Abstract] [Full Text] [Related]

  • 14. HSV-tk gene therapy for human renal cell carcinoma in nude mice.
    Pulkkanen KJ, Parkkinen JJ, Laukkanen JM, Kettunen MI, Tyynela K, Kauppinen RA, Ala-Opas MY, Yla-Herttuala S.
    Cancer Gene Ther; 2001 Jul 15; 8(7):529-36. PubMed ID: 11498775
    [Abstract] [Full Text] [Related]

  • 15. Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinoma.
    Tsuchiyama T, Kaneko S, Nakamoto Y, Sakai Y, Honda M, Mukaida N, Kobayashi K.
    Cancer Gene Ther; 2003 Apr 15; 10(4):260-9. PubMed ID: 12679798
    [Abstract] [Full Text] [Related]

  • 16. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
    Ebara S, Shimura S, Nasu Y, Kaku H, Kumon H, Yang G, Wang J, Timme TL, Aguilar-Cordova E, Thompson TC.
    Prostate Cancer Prostatic Dis; 2002 Apr 15; 5(4):316-25. PubMed ID: 12627218
    [Abstract] [Full Text] [Related]

  • 17. Transduction efficacy, antitumoral effect, and toxicity of adenovirus-mediated herpes simplex virus thymidine kinase/ ganciclovir therapy of hepatocellular carcinoma: the woodchuck animal model.
    Bilbao R, Gérolami R, Bralet MP, Qian C, Tran PL, Tennant B, Prieto J, Bréchot C.
    Cancer Gene Ther; 2000 May 15; 7(5):657-62. PubMed ID: 10830712
    [Abstract] [Full Text] [Related]

  • 18. Application of the Cre recombinase/loxP system further enhances antitumor effects in cell type-specific gene therapy against carcinoembryonic antigen-producing cancer.
    Kijima T, Osaki T, Nishino K, Kumagai T, Funakoshi T, Goto H, Tachibana I, Tanio Y, Kishimoto T.
    Cancer Res; 1999 Oct 01; 59(19):4906-11. PubMed ID: 10519403
    [Abstract] [Full Text] [Related]

  • 19. HVJ-liposome-mediated transfection of HSVtk gene driven by AFP promoter inhibits hepatic tumor growth of hepatocellular carcinoma in SCID mice.
    Hirano T, Kaneko S, Kaneda Y, Saito I, Tamaoki T, Furuyama J, Tamaoki T, Kobayashi K, Ueki T, Fujimoto J.
    Gene Ther; 2001 Jan 01; 8(1):80-3. PubMed ID: 11402306
    [Abstract] [Full Text] [Related]

  • 20. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
    Hasegawa H, Shimada M, Yonemitsu Y, Utsunomiya T, Gion T, Kaneda Y, Sugimachi K.
    Cancer Gene Ther; 2001 Apr 01; 8(4):252-8. PubMed ID: 11393277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.